2011
DOI: 10.1016/j.vaccine.2011.04.078
|View full text |Cite
|
Sign up to set email alerts
|

Strategies to vaccinate against cancer of the cervix: Feasibility of a school-based HPV vaccination program in Peru

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
47
0

Year Published

2012
2012
2017
2017

Publication Types

Select...
7

Relationship

2
5

Authors

Journals

citations
Cited by 41 publications
(49 citation statements)
references
References 12 publications
2
47
0
Order By: Relevance
“…Consistent with this, in Bolivia and Ecuador, CC is the leading cause of female cancer deaths [1]. Since 2006, prophylactic primary prevention against the 70-75% of CC due to high risk (HR) HPV-16 and -18 has been available from the heat-labile bivalent (2vHPV) and quadrivalent (4vHPV) vaccinations [3][4][5]. The 96.5% efficacious nonavalent (9vHPV) vaccine affords additional primary prevention from CC due to HR HPV-31, -33, -45, -52, -58 [6].…”
Section: Introductionmentioning
confidence: 80%
See 1 more Smart Citation
“…Consistent with this, in Bolivia and Ecuador, CC is the leading cause of female cancer deaths [1]. Since 2006, prophylactic primary prevention against the 70-75% of CC due to high risk (HR) HPV-16 and -18 has been available from the heat-labile bivalent (2vHPV) and quadrivalent (4vHPV) vaccinations [3][4][5]. The 96.5% efficacious nonavalent (9vHPV) vaccine affords additional primary prevention from CC due to HR HPV-31, -33, -45, -52, -58 [6].…”
Section: Introductionmentioning
confidence: 80%
“…Peruvian women have a background HPV prevalence of 17.7% versus a global rate of 10% [16]. At 32.7 per 100,000 women, Peru's CC age-standardized incidence (ASI) is twice that of low-and middle-income countries (LMIC) overall (17.7), and higher than most South American countries (Table 1) [1,4,5,35]. The increased Peruvian CC ASI is attributable to low cytology cover at 51.30, due to a 40.3% Papanicolaou (Pap) test rate, 42.5% sensitivity for cervical intraepithelial neoplasia grade 3 (CIN3), and the 1.7-fold higher Peruvian background HPV rate [2,35].…”
Section: Population Specific Prevalence and Sequela Of Hpv In The Andmentioning
confidence: 99%
“…[11][12][13][14][15][16][17] For school-based outreach, vaccine coverage was 82.6% in Peru, 88.9% in Uganda and Objective To estimate the incremental delivery cost of human papillomavirus (HPV) vaccination of young adolescent girls in Peru, Uganda and Viet Nam. Methods Data were collected from a sample of facilities that participated in five demonstration projects for HPV vaccine delivery: schoolbased delivery was used in Peru, Uganda and Viet Nam; health-centre-based delivery was also used in Viet Nam; and integrated delivery, which involved existing health services, was also used in Uganda.…”
Section: Introductionmentioning
confidence: 99%
“…23,25,38,[41][42][43] Demonstration programs through the international non-governmental organization PATH have achieved high coverage through school-based delivery in Peru (82.6%), Uganda (88.9%) and Vietnam (96.1%). 42 High coverage has also been seen in school-based demonstration projects in South Africa, 44 Brazil, 45 and Nepal.…”
Section: Hpv Vaccination Implementation Approaches School Based Appromentioning
confidence: 99%
“…25,42,43 Community approaches are also generally paired with other strategies for a mixed approach to achieve vaccination. A school-based vaccination program in combination with existing community-based childfocused public health campaign was used in Uganda, in order to reach out-of-school girls.…”
Section: Community Outreach Approachesmentioning
confidence: 99%